Medline: FDA, Industry Experts Raise Concerns Over Company’s Oversight of Contract Manufacturers and Ability to Monitor Device Malfunctions

A Capitol Forum investigation has found that poor oversight of its suppliers and post-market surveillance practices by the medical device company Medline (MDLN) is leading to patient harm and delayed recalls of dangerous products. Over the last several years, FDA inspectors have repeatedly cited the company for these failures, and industry experts are expressing concern […]